CompletedPhase 3NCT01603407
Finding the Optimum Regimen for Duchenne Muscular Dystrophy
Studying Duchenne muscular dystrophy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Rochester
- Principal Investigator
- Robert C. Griggs, MDUniversity of Rochester
- Intervention
- Prednisone(drug)
- Enrollment
- 196 enrolled
- Eligibility
- 4-7 years · MALE
- Timeline
- 2013 – 2019
Study locations (30)
- University of California Los Angeles (UCLA) Medical Center, Los Angeles, California, United States
- University of California Davis Medical Center, Sacramento, California, United States
- Children's National Medical Center, Washington D.C., District of Columbia, United States
- Nemours Children's Hospital, Orlando, Florida, United States
- Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States
- University of Kansas Medical Center, Kansas City, Kansas, United States
- Boston Children's Hospital, Boston, Massachusetts, United States
- University of New Mexico Health Science Center, Albuquerque, New Mexico, United States
- University of Rochester Medical Center, Rochester, New York, United States
- University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States
- Nationwide Children's Hospital, Columbus, Ohio, United States
- Penn State Hershey Medical Center, Hershey, Pennsylvania, United States
- Vanderbilt Children's Hospital, Nashville, Tennessee, United States
- University of Utah Medical Center, Salt Lake City, Utah, United States
- Alberta Children's Hospital, Calgary, Alberta, Canada
- +15 more locations on ClinicalTrials.gov
Collaborators
Newcastle University · University Medical Center Freiburg · National Institute of Neurological Disorders and Stroke (NINDS)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01603407 on ClinicalTrials.govOther trials for Duchenne muscular dystrophy
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07332013Urinary Titin Biomarker in DMDChildren's Hospital of Philadelphia
- RECRUITINGNCT07092540The Baby Duchenne Study: Characterizing Developmental and Clinical Outcomes in the First Three Years in Children With Duchenne Muscular DystrophyUniversity of Rochester
- ENROLLING BY INVITATIONNANCT06887491The Effect of Dual-tasking Program on Cognitive and Physical Functions and Independence in Activities of Daily Living in Children With Duchenne Muscular Dystrophy: A Single-blind Randomized Controlled TrialLokman Hekim University
- ACTIVE NOT RECRUITINGPHASE1NCT07347548A Trial to Investigate the Safety and Pharmacokinetics of GRT6019 in Healthy Male ParticipantsGrünenthal GmbH
- ENROLLING BY INVITATIONPHASE2NCT07209332Open-Label Extension Study of WVE-N531 in Patients With Duchenne Muscular DystrophyWave Life Sciences Ltd.
- ACTIVE NOT RECRUITINGEARLY PHASE1NCT07282652A Study to Evaluate the Safety and Tolerability of RAG-18 in Pediatric Patients With Duchenne Muscular DystrophyPeking Union Medical College Hospital
- RECRUITINGPHASE2NCT07287189Phase 2 Study of SAT-3247 in Pediatric Ambulatory PatientsSatellos Bioscience, Inc.
- ENROLLING BY INVITATIONNCT07435116Duchenne Muscular Dystrophy and the Viscoelastic Properties of Upper Limb MusclesSanko University